TABLE 1.
Time (h postinfection) | Pathophysiologic events | Clinical symptoms |
---|---|---|
0 | Bacteria and bacterial products accumulate in CSF | None |
4 | Release of inflammatory mediators and cytokines | Fever |
8-24 | Blood-brain barrier disruption; development of cerebral edema; transendothelial migration of leukocytes; more proinflammatory and toxic mediators; followed by impaired cerebral blood flow, elevated intracranial pressure, and vasculitis | Elevated CSF protein; meningism/neck stiffness; elevated CSF leukocytosis; possible systemic complications; followed by altered mental status, focal symptoms, and seizures |
24-48 | Neuronal injury | Focal symptoms; hearing loss; paralysis; cognitive impairment; death |